National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

Eva Rath; Michael Bonelli; Herwig Pieringer; Holger Flick; Helmut Salzer; G. Weiss; S. Winkler; Alexander Moschen; et al.

doi:10.1007/s00508-022-02062-7

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

Eva Rath
, Michael Bonelli
, Herwig Pieringer
, Holger Flick
, Helmut Salzer
, G. Weiss
, S. Winkler
, Alexander Moschen
, et al.

Universitätsklinik für Innere Medizin 4 - Pneumologie und Infektiologie

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	751-765
Seitenumfang	15
Fachzeitschrift	Wiener klinische Wochenschrift
Volume	134
Ausgabenummer	21-22
DOIs	https://doi.org/10.1007/s00508-022-02062-7
Publikationsstatus	Veröffentlicht - Aug. 2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

302030 Innere Medizin
302068 Pulmologie

Zugriff auf Dokument

10.1007/s00508-022-02062-7

Andere Dateien und Links

Dieses zitieren

Rath, E., Bonelli, M., Pieringer, H., Flick, H., Salzer, H., Weiss, G., Winkler, S., Moschen, A., & et al. (2022). National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). Wiener klinische Wochenschrift, 134(21-22), 751-765. https://doi.org/10.1007/s00508-022-02062-7

Rath, Eva ; Bonelli, Michael ; Pieringer, Herwig et al. / National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). in: Wiener klinische Wochenschrift. 2022 ; Jahrgang/Volume 134, Nr. 21-22. S. 751-765.

@article{0b71acfd41044fbe846febdeb0d8652b,

title = "National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)",

author = "Eva Rath and Michael Bonelli and Herwig Pieringer and Holger Flick and Helmut Salzer and G. Weiss and S. Winkler and Alexander Moschen and \{et al.\}",

year = "2022",

month = aug,

doi = "10.1007/s00508-022-02062-7",

language = "English",

volume = "134",

pages = "751--765",

journal = "Wiener klinische Wochenschrift",

issn = "1613-7671",

publisher = "Springer",

number = "21-22",

}

Rath, E, Bonelli, M, Pieringer, H, Flick, H, Salzer, H, Weiss, G, Winkler, S, Moschen, A & et al. 2022, 'National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)', Wiener klinische Wochenschrift, Jg. 134, Nr. 21-22, S. 751-765. https://doi.org/10.1007/s00508-022-02062-7

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). / Rath, Eva; Bonelli, Michael; Pieringer, Herwig et al.
in: Wiener klinische Wochenschrift, Volume 134, Nr. 21-22, 08.2022, S. 751-765.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)

AU - Rath, Eva

AU - Bonelli, Michael

AU - Pieringer, Herwig

AU - Flick, Holger

AU - Salzer, Helmut

AU - Weiss, G.

AU - Winkler, S.

AU - Moschen, Alexander

AU - et al., null

PY - 2022/8

Y1 - 2022/8

UR - https://pubmed.ncbi.nlm.nih.gov/36036323/

UR - https://www.scopus.com/pages/publications/85137227643

U2 - 10.1007/s00508-022-02062-7

DO - 10.1007/s00508-022-02062-7

M3 - Article

C2 - 36036323

SN - 1613-7671

VL - 134

SP - 751

EP - 765

JO - Wiener klinische Wochenschrift

JF - Wiener klinische Wochenschrift

IS - 21-22

ER -

Rath E, Bonelli M, Pieringer H, Flick H, Salzer H, Weiss G et al. National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). Wiener klinische Wochenschrift. 2022 Aug.;134(21-22):751-765. doi: 10.1007/s00508-022-02062-7